Vanberra Signal

Rayca

Curated by Signal

AI-powered platform for precision oncology and clinical research

Overview

AI-powered platform for precision oncology and clinical research. The company offers OncoCrest which employs artificial intelligence (AI) and gene expression profiling to enable predictive modeling of drug responses in the realm of cancer therapeutic and RSA2 an analytical platform for the clinical research industry.

Key facts

Founded
2021

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of an app for cognitive training

    Health TechnologyCambridge, United Kingdom
  • Provider of online gym for training

    Health TechnologyLondon, United Kingdom
  • Online e-learning platform for medical surgery

    Health TechnologyCardiff, United Kingdom

About Rayca

What does Rayca do?

AI-powered platform for precision oncology and clinical research.

Where is Rayca headquartered?

Rayca is headquartered in London, United Kingdom.

When was Rayca founded?

Rayca was founded in 2021.

Which sector is Rayca in?

Rayca operates in Health Technology.

Who are Rayca's competitors?

Companies similar to Rayca include EQ Mindware, QLMTeleGym, and SPD Academy.